Fresh issue of Rs 2,500 million
Offer for Sale of upto 6,269,558 shares by promoters and PE investor
The minimum Bid lot is 45 equity shares and in multiples of 45 equity shares thereafter
Issue opening date – 8th February, 2016 and closing date – 10th February, 2016
Quick Heal Technologies Limited will hit the capital markets with its IPO on February 08, 2016 with a price band of Rs. 311 to Rs. 321 per equity share of face value of Rs. 10 each.
The IPO consists of a fresh issue of Rs 2,500 million by the Company and an offer for sale of upto 6,269,558 equity shares by promoters Kailash Sahebrao Katkar and Sanjay Sahebrao Katkar, apart from Sequoia Capital India Investment Holdings III and Sequoia Capital India Investments III.
The Issue is being made through the Book Building Process wherein 50% of the offer will be allocated on a proportionate basis to Qualified Institutional Buyers (QIB’s), provided that the Company and the Selling Shareholders, in consultation with the BRLMs, may allocate up to 60% of the QIB Category to Anchor Investors, on a discretionary basis (the “Anchor Investor Portion”), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Offer Price.
Further, not less than 15% of the Net Offer will be available for allocation on a proportionate basis to Non-Institutional Investors and not less than 35% of the Net Offer will be available for allocation to Retail Individual Investors, in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. Equity Shares aggregating up to Rs. 50 million shall be made available for allocation on a proportionate basis to the Eligible Employees Bidding in the Employee Reservation Portion, subject to valid Bids being received at or above the Offer Price. All Investors (except Anchor Investors) shall participate in this Offer only through the ASBA process.
ICICI Securities Limited, Jefferies India Private Limited, and J. P. Morgan India Private Limited are the Book Running Lead Managers while Link Intime India Private Limited is the registrar.
The offer would constitute [●]% of the Company’s post-issue paid-up equity share capital and the net offer would constitute [●] % of its post-issue paid-up equity share capital.
Quick Heal’s equity shares are proposed to be listed on the BSE and the NSE.
"QUICK HEAL TECHNOLOGIES LIMITED is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares and has filed a red herring prospectus dated January 29, 2016 ("RHP") with the Registrar of Companies, Pune, Maharashtra. The RHP is available on the website of SEBI at www.sebi.gov.in and the websites of the Book Running Lead Managers at www.icicisecurities.com, www.jefferies.com and www.jpmorgan.com. Any potential investor should note that investment in Equity Shares involves a high degree of risk. For details, potential investors should refer to the section titled “Risk Factors” in the RHP. Investors should not refer to the DRHP for making any investment decision."
US LAW DISCLAIMER:
THIS PRESS RELEASE IS NOT AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING THE UNITED STATES. ANY OFFERING TO BE MADE WILL BE MADE BY A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER AND THE SELLING SHAREHOLDERS AND WILL CONTAIN DETAIL INFORMATION ABOUT THE COMPANY , MANAGEMENT AND FINANCIAL STATEMENTS.
THE EQUITY SHARES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT, AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE U.S. STATE SECURITIES LAWS. ACCORDINGLY, THE EQUITY SHARES ARE BEING OFFERED AND SOLD (I) WITHIN THE UNITED STATES TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL INVESTORS (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT); AND (II) OUTSIDE THE UNITED STATES IN OFFSHORE TRANSACTIONS IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT AND APPLICABLE LAWS OF THE JURISDICTIONS WHERE SUCH OFFERS AND SALES OCCUR.